p16 controls epithelial cell growth and suppresses carcinogenesis through mechanisms that do not require RB1 function

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• The p16/RB1 pathway is crucial for tumor suppression but is frequently inactivated in human cancers.
• p16 is often lost preferentially, suggesting functions independent of RB1.
• Understanding this pathway in lung epithelium is vital, as lung cancer is a leading cause of cancer death.

Purpose of the Study:

• To investigate the specific role of p16 in lung epithelial cells following RB1 loss.
• To determine if p16 loss contributes to genetic instability and tumor formation in the absence of RB1.
• To elucidate the mechanism by which p16 functions in lung tumorigenesis.

Main Methods:

• Utilized genetically engineered mouse models with targeted ablation of RB1 in lung epithelium.
• Analyzed p16 expression and cellular responses (senescence, DNA damage) in RB1-deficient lung cells.
• Assessed the impact of combined RB1 and p16 deficiency on lung tumor development and metastasis.

Main Results:

• p16 was upregulated in RB1-deficient lung epithelium, unlike in fibroblasts.
• p16 upregulation promoted survival of RB1-deficient cells by protecting against DNA damage, not inducing senescence.
• Combined RB1 and p16 loss led to genetic instability, immortalization, and aggressive metastatic lung cancers.

Conclusions:

• p16 loss is a critical event driving genetic instability and lung tumorigenesis, independent of RB1.
• p16 directly protects RB1-deficient cells from DNA damage, explaining its preferential loss in human cancers.
• Targeting p16 loss may offer new therapeutic strategies for lung cancer.